Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-20 of 68
Keywords: Multiple sclerosis
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Journal Articles
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2023) 30 (1): 291–301.
Published Online: 12 October 2023
...James M. Nichols; Barbara L.F. Kaplan Introduction: Multiple sclerosis (MS) is a neurodegenerative autoimmune disease that worsens with age. Here, we examined the influence of age on passive experimental autoimmune encephalomyelitis (P-EAE), a model to study MS, using young and mature adult 2D2...
Journal Articles
Ali Amini Harandi, Fatemeh Siavoshi, Siavash Shirzadeh Barough, Asghar Amini Harandi, Hossein Pakdaman, Mohammad Ali Sahraian, Zahra Fathtabar, Faezeh Mohammadi, Faezeh Karamiani, Seyed Hossein Ardehali
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2022) 29 (4): 476–485.
Published Online: 18 August 2022
... in the development and progression of multiple sclerosis (MS). Vascular endothelial growth factor (VEGF) is one of the key factors involved in angiogenesis. Because of this importance, we investigated the serum levels of VEGF in MS patients according to their clinical phase and subtype of MS in this study. Material...
Journal Articles
Subject Area:
Topic Article Package: Moksha
,
Endocrinology
,
Immunology and Allergy
,
Neurology and Neuroscience
Hai Duc Nguyen, Ngoc Minh Hong Hoang, Myeonghee Ko, Dongjin Seo, Shinhyun Kim, Won Hee Jo, Jung-Woo Bae, Min-Sun Kim
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2022) 29 (2): 85–96.
Published Online: 05 April 2022
...) focusing on NDs (including Parkinson’s disease, Alzheimer’s disease, Huntington’s disease [HD], multiple sclerosis [MS], and epilepsy) were reported. The meta-analysis showed that there was no statistically significant difference in serum PRL levels between patients with NDs and healthy controls (SMD...
Journal Articles
Subject Area:
Topic Article Package: Coronavirus (COVID-19)
,
Endocrinology
,
Immunology and Allergy
,
Neurology and Neuroscience
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2022) 29 (4): 251–254.
Published Online: 02 March 2022
..., resulting in several neurological complications. It was previously assumed that some coronaviruses are involved in multiple sclerosis (MS) pathology via various mechanisms. The mechanisms involved in coronavirus-induced central demyelination are complex and largely redundant. Molecular mimicry was proposed...
Journal Articles
Distinct Immunological Features of Inflammatory Demyelinating Diseases of the Central Nervous System
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2022) 29 (3): 220–230.
Published Online: 25 November 2021
...Bo Chen; Meng-Cui Gui; Su-Qiong Ji; Yi Xie; Dai-Shi Tian; Bi-Tao Bu Objective: The immunological features between neuromyelitis optica spectrum disorder (NMOSD), multiple sclerosis (MS), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), lacked systemic comparisons...
Journal Articles
Ahmed M.B. Khedr, Olfat Gamil Shaker, Amr Hassan, Mona Hussein, Yasmine S. Kamal, Taha Abdelraziq Azouz
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2022) 29 (2): 128–134.
Published Online: 17 September 2021
...Ahmed M.B. Khedr; Olfat Gamil Shaker; Amr Hassan; Mona Hussein; Yasmine S. Kamal; Taha Abdelraziq Azouz Introduction: Multiple sclerosis (MS) is known to be a multifactorial disorder. Numerous observational studies have suggested the implication of multiple genetic and environmental factors...
Journal Articles
Subject Area:
Topic Article Package: Moksha
,
High Impact Articles in Immunology and Allergy
,
Endocrinology
,
Immunology and Allergy
,
Neurology and Neuroscience
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2022) 29 (1): 4–14.
Published Online: 08 September 2021
... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Astrocytes Curcumin Alzheimer’s disease Parkinson’s disease Multiple sclerosis Huntington’s disease Neurodegenerative diseases...
Journal Articles
Subject Area:
Topic Article Package: Moksha
,
Endocrinology
,
Immunology and Allergy
,
Neurology and Neuroscience
Arnon Dias Jurberg, Beatriz Chaves, Lia Gonçalves Pinho, João Hermínio Martins da Silva, Wilson Savino, Vinicius Cotta-de-Almeida
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2021) 28 (4): 213–221.
Published Online: 02 September 2021
... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Integrin Migration T cells Multiple sclerosis Natalizumab A growing number of individuals diagnosed...
Journal Articles
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2021) 28 (3): 118–128.
Published Online: 02 July 2021
...Xiaofan Yuan; Lei Guo; Chuan Jiang; Xu Yang; Jie Huang Background: Despite the vitamin D treatment in patients with multiple sclerosis (MS), there continues to be controversial discrepancy in outcomes according to the current research. Many systematic reviews have evaluated the effect of vitamin D...
Journal Articles
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2021) 28 (3): 150–157.
Published Online: 28 June 2021
...Mansour Shajarian; Fereshteh Alsahebfosoul; Masoud Etemadifar Background: In recent investigations addressing neurodegenerative diseases, especially multiple sclerosis (MS), the roles of brain-derived neurotrophic factor (BDNF) and interleukin-6 (IL-6) have been examined. Methods: Forty-five...
Journal Articles
Fatemeh Lotfi, Marjan Mansourian, Omid Mirmoayyeb, Soroush Najdaghi, Vahid Shaygannejad, Nafiseh Esmaeil
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2022) 29 (1): 21–27.
Published Online: 16 June 2021
...Fatemeh Lotfi; Marjan Mansourian; Omid Mirmoayyeb; Soroush Najdaghi; Vahid Shaygannejad; Nafiseh Esmaeil The association between air pollution and multiple sclerosis (MS) is not entirely clear. This meta-analysis was aimed at determining the correlation between particulate matter (PM)2.5, PM10...
Journal Articles
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2021) 28 (4): 195–203.
Published Online: 27 May 2021
.... This review summarizes and discusses the recent studies investigating the regulatory roles of the caspase-11 noncanonical inflammasome in neuroinflammation and the pathogenesis of multiple sclerosis (MS), which provides the insight for the validation of caspase-11 noncanonical inflammasome to develop novel...
Journal Articles
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2020) 27 (4): 163–177.
Published Online: 10 March 2021
...Mohammad Sadegh Hesamian; Nahid Eskandari Multiple sclerosis (MS) is an unpredictable disease of the central nervous system. The cause of MS is not known completely, and pathology is specified by involved demyelinated areas in the white and gray matter of the brain and spinal cord. Inflammation...
Journal Articles
Mohsen Ebrahimi Monfared, Shima Shapoori, Ghasem Mosayebi, Behzad Khansarinejad, Ali Ghazavi, Masoud Rezagholizamenjany, Ali Ganji
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2020) 26 (6): 301–306.
Published Online: 14 January 2020
...Mohsen Ebrahimi Monfared; Shima Shapoori; Ghasem Mosayebi; Behzad Khansarinejad; Ali Ghazavi; Masoud Rezagholizamenjany; Ali Ganji Introduction: Multiple sclerosis (MS) is a neuroinflammatory autoimmune disease which involves the central nervous -system. Although the primary cause of MS is obscure...
Journal Articles
Iara Barreto Neves Oliveira, Rodrigo Saar Gomes, Larissa Fonseca Gomides, Jéssica Cristina dos Santos, Marcos Alexandre Diniz Carneiro, Fátima Ribeiro-Dias, Denise Sisterolli Diniz
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2019) 26 (2): 77–83.
Published Online: 21 March 2019
...Iara Barreto Neves Oliveira; Rodrigo Saar Gomes; Larissa Fonseca Gomides; Jéssica Cristina dos Santos; Marcos Alexandre Diniz Carneiro; Fátima Ribeiro-Dias; Denise Sisterolli Diniz Objective: Multiple sclerosis (MS) is a multifactorial chronic disease that affects the central nervous system (CNS...
Journal Articles
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2019) 25 (4): 185–192.
Published Online: 13 November 2018
...Baozhu Liu; Xiaonan Zhong; Zhengqi Lu; Wei Qiu; Xueqiang Hu; Honghao Wang Object: CD27 belongs to the tumor necrosis factor receptor family and is constitutively expressed on T cells. The concentration of cerebrospinal fluid (CSF) soluble (s)CD27 is elevated in patients with multiple sclerosis (MS...
Journal Articles
Anton Glasnović, Maristela Stojić, Lidija Dežmalj, Ivana Tudorić-Đeno, Dominik Romić, Vjekoslav Jeleč, Anđelko Vrca, Vladimira Vuletić, Danka Grčević
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2018) 25 (1): 23–33.
Published Online: 16 August 2018
... proinflammatory/immunoregulatory upstream mediators in the peripheral blood (PBL) and cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients. Methods: PBL and CSF were collected from healthy controls ( n = 35) and MS patients at the clinical onset of the disease ( n = 33). In addition, PBL samples were...
Journal Articles
Gholamreza Asadikaram, Saam Noroozi, Hossein Ali Ebrahimi Meimand, Mojgan Sanjari, Nahid Zainodini, Hossein Khoramdelazad, Nader Shahrokhi, Mohammad Kazemi Arababadi
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2017) 23 (5-6): 345–351.
Published Online: 22 April 2017
...Gholamreza Asadikaram; Saam Noroozi; Hossein Ali Ebrahimi Meimand; Mojgan Sanjari; Nahid Zainodini; Hossein Khoramdelazad; Nader Shahrokhi; Mohammad Kazemi Arababadi Objectives: Interferon-β 1a (IFN-β 1a) is a common strategy therapy for multiple sclerosis (MS) with unknown mechanisms. S100A12...
Journal Articles
Rong Zhong, Junyan Liang, Ailin Tao, Linzhan Wu, Xinguang Yang, Huiming Xu, Qingmei Huang, Shunzhi Zhuang, Youming Long, Cong Gao
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2017) 23 (5-6): 295–300.
Published Online: 08 April 2017
...Rong Zhong; Junyan Liang; Ailin Tao; Linzhan Wu; Xinguang Yang; Huiming Xu; Qingmei Huang; Shunzhi Zhuang; Youming Long; Cong Gao Objectives: The aim of this study was to explore the frequency of KIR4.1 antibodies in patients with multiple sclerosis (MS) and in control groups using a cell-based...
Journal Articles
Journal:
Neuroimmunomodulation
Neuroimmunomodulation (2017) 23 (4): 197–208.
Published Online: 29 November 2016
...Mojgan Noroozi Karimabad; Soudeh Khanamani Falahati-pour; Gholamhossein Hassanshahi Both cellular and molecular components of the immune system are among the substantial factors involved in the pathogenesis of multiple sclerosis (MS). Accumulating evidence confirms that chemokines, as the main...
1